Sarah E Grady1, Travis A Marsh2, Allison Tenhouse3, Kelsey Klein4. 1. Associate Professor, Department of Clinical Sciences, Drake University College of Pharmacy & Health Sciences, Des Moines, Iowa, sarah.grady@drake.edu. 2. Pharmacist, Walgreens Pharmacy, Scottsdale, Arizona. 3. PGY-1 Pharmacy Practice Resident, Blessing Hospital, Quincy, Illinois. 4. PharmD Candidate, Drake University College of Pharmacy & Health Sciences, Des Moines, Iowa.
Abstract
INTRODUCTION: Over the past decade, ketamine has been studied for major depressive disorder and bipolar depression. Ketamine is believed to exert its antidepressant properties through N-methyl-D-aspartate receptor antagonism. METHODS: Study authors completed a literature review of seven randomized controlled trials of ketamine usage in major depressive disorder and bipolar depression. RESULTS: Ketamine demonstrated a statistically significant improvement over placebo or midazolam in major depressive disorder. Ketamine also exhibited a statistically significant improvement over placebo in bipolar depression. DISCUSSION: Ketamine has shown promise in quickly reducing symptoms in patients with treatment resistant depression and bipolar depression. Using ketamine may be helpful for patients that have exhausted other therapeutic options.
INTRODUCTION: Over the past decade, ketamine has been studied for major depressive disorder and bipolar depression. Ketamine is believed to exert its antidepressant properties through N-methyl-D-aspartate receptor antagonism. METHODS: Study authors completed a literature review of seven randomized controlled trials of ketamine usage in major depressive disorder and bipolar depression. RESULTS: Ketamine demonstrated a statistically significant improvement over placebo or midazolam in major depressive disorder. Ketamine also exhibited a statistically significant improvement over placebo in bipolar depression. DISCUSSION: Ketamine has shown promise in quickly reducing symptoms in patients with treatment resistant depression and bipolar depression. Using ketamine may be helpful for patients that have exhausted other therapeutic options.
Authors: R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal Journal: Biol Psychiatry Date: 2000-02-15 Impact factor: 13.382
Authors: Carlos A Zarate; Nancy E Brutsche; Lobna Ibrahim; Jose Franco-Chaves; Nancy Diazgranados; Anibal Cravchik; Jessica Selter; Craig A Marquardt; Victoria Liberty; David A Luckenbaugh Journal: Biol Psychiatry Date: 2012-01-31 Impact factor: 13.382
Authors: Kyle A B Lapidus; Cara F Levitch; Andrew M Perez; Jess W Brallier; Michael K Parides; Laili Soleimani; Adriana Feder; Dan V Iosifescu; Dennis S Charney; James W Murrough Journal: Biol Psychiatry Date: 2014-04-03 Impact factor: 13.382
Authors: Jih-Heng Li; Balasingam Vicknasingam; Yuet-Wah Cheung; Wang Zhou; Adhi Wibowo Nurhidayat; Don C Des Jarlais; Richard Schottenfeld Journal: Subst Abuse Rehabil Date: 2011-03-16
Authors: Valerie J Sydnor; Amanda E Lyall; Suheyla Cetin-Karayumak; Joey C Cheung; Julia M Felicione; Oluwaseun Akeju; Martha E Shenton; Thilo Deckersbach; Dawn F Ionescu; Ofer Pasternak; Cristina Cusin; Marek Kubicki Journal: Transl Psychiatry Date: 2020-12-15 Impact factor: 6.222